Emerging and Novel Treatments for Pituitary Tumors

by Mirela Diana Ilie, Hélène Lasolle, Gérald Raverot
Published 2019-07-01

Pasireotide-LAR in acromegaly patients treated with a combination therapy: a real-life study

by Hélène Lasolle, Amandine Ferriere, Alexandre Vasiljevic, Sandrine Eimer, Marie-Laure Nunes, Antoine Tabarin
Published 2019-10-01

SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors

by Solène Castellnou, Alexandre Vasiljevic, Véronique Lapras, Véronique Raverot, Eudeline Alix, Françoise Borson-Chazot, Emmanuel Jouanneau, Gérald Raverot, Hélène Lasolle
Published 2020-03-01

Age- and Sex-Specific TSH Upper-Limit Reference Intervals in the General French Population: There Is a Need to Adjust Our Actual Practices

by Véronique Raverot, Maxime Bonjour, Juliette Abeillon du Payrat, Pauline Perrin, Florence Roucher-Boulez, Helene Lasolle, Fabien Subtil, Françoise Borson-Chazot
Published 2020-03-01

Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis

by Hélène Lasolle, Mad-Hélénie Elsensohn, Anne Wierinckx, Eudeline Alix, Clément Bonnefille, Alexandre Vasiljevic, Christine Cortet, Bénédicte Decoudier, Nathalie Sturm, Stephan Gaillard, Amandine Ferrière, Pascal Roy, Emmanuel Jouanneau, Philippe Bertolino, Claire Bardel, Damien Sanlaville, Gérald Raverot
Published 2020-11-01